scout
News|Videos|November 7, 2023

PSMAfore: Lutetium-177–PSMA-617 in Metastatic CRPC

Shared insight from Rana McKay, MD, and the Oncology Brothers on updated data from PSMAfore and the use of Lutetium-177–PSMA-617 in patients with metastatic castration-resistant prostate cancer.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME